Targeting signaling pathways in glomerular diseases - PubMed (original) (raw)
Review
Targeting signaling pathways in glomerular diseases
Carole Henique et al. Curr Opin Nephrol Hypertens. 2012 Jul.
Abstract
Purpose of review: Podocytes are highly specialized epithelial cells that line the urinary surface of the glomerular capillary tuft. Dysfunction or death of podocytes impacts glomerular permeability and filtration. Here, we discuss the recent findings about the role of specific cell signaling pathways in glomerular diseases with an emphasis on the molecules in the podocyte that represent candidate therapeutic targets.
Recent findings: A number of local endogenous factors that retard the progression of diabetic nephropathy have recently been identified and include angiopoietin-1 (Angpt1), Smad7 and nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Calcium-dependent regulation of podocyte actin dynamics involving transient receptor potential canonical (TRPC) channels and the Rho and Rac small GTPases has been shown to play important functions in glomerular health and disease. A central role for mammalian target of rapamycin (mTOR) activation in the development of diabetic nephropathy and regulation of autophagic flux in podocytes during aging has been demonstrated. Discovery of a circulating factor (suPAR) that can modulate outside-in beta3 integrin signaling in recurrent focal segmental glomerulosclerosis provides exciting therapeutic possibilities. Another secreted factor, the hyposialylated form of angiopoietin-like-protein 4 (ANGPTL4) was found to favor albuminuria in rats and in minimal change disease. Therapeutic sialylation of ANGPTL4 could limit albuminuria. Finally, neutralization of de novo paracrine activation of glomerular epithelial cells by heparin-binding epidermal growth factor (EGF)-like growth factor or EGF receptor antagonists could limit crescent formation and renal failure in immune-mediated vasculitis.
Summary: Here, we review the recent developments in our understanding of signaling pathways required for podocyte function in health and disease. Manipulation of these pathways provides an attractive therapeutic option for glomerular diseases.
Similar articles
- Targeting podocyte-associated diseases.
Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R. Leeuwis JW, et al. Adv Drug Deliv Rev. 2010 Nov 30;62(14):1325-36. doi: 10.1016/j.addr.2010.08.012. Epub 2010 Sep 7. Adv Drug Deliv Rev. 2010. PMID: 20828590 Review. - Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.
Tian X, Ishibe S. Tian X, et al. Nephrol Dial Transplant. 2016 Oct;31(10):1577-83. doi: 10.1093/ndt/gfw021. Epub 2016 Mar 10. Nephrol Dial Transplant. 2016. PMID: 26968197 Free PMC article. Review. - mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes.
Vollenbröker B, George B, Wolfgart M, Saleem MA, Pavenstädt H, Weide T. Vollenbröker B, et al. Am J Physiol Renal Physiol. 2009 Feb;296(2):F418-26. doi: 10.1152/ajprenal.90319.2008. Epub 2008 Nov 19. Am J Physiol Renal Physiol. 2009. PMID: 19019920 - Glomerular parietal epithelial cells in kidney physiology, pathology, and repair.
Shankland SJ, Anders HJ, Romagnani P. Shankland SJ, et al. Curr Opin Nephrol Hypertens. 2013 May;22(3):302-9. doi: 10.1097/MNH.0b013e32835fefd4. Curr Opin Nephrol Hypertens. 2013. PMID: 23518463 Review. - Insulin increases glomerular filtration barrier permeability through PKGIα-dependent mobilization of BKCa channels in cultured rat podocytes.
Piwkowska A, Rogacka D, Audzeyenka I, Kasztan M, Angielski S, Jankowski M. Piwkowska A, et al. Biochim Biophys Acta. 2015 Aug;1852(8):1599-609. doi: 10.1016/j.bbadis.2015.04.024. Epub 2015 May 4. Biochim Biophys Acta. 2015. PMID: 25952906
Cited by
- Kindlin-2 Association with Rho GDP-Dissociation Inhibitor α Suppresses Rac1 Activation and Podocyte Injury.
Sun Y, Guo C, Ma P, Lai Y, Yang F, Cai J, Cheng Z, Zhang K, Liu Z, Tian Y, Sheng Y, Tian R, Deng Y, Xiao G, Wu C. Sun Y, et al. J Am Soc Nephrol. 2017 Dec;28(12):3545-3562. doi: 10.1681/ASN.2016091021. Epub 2017 Aug 3. J Am Soc Nephrol. 2017. PMID: 28775002 Free PMC article. - Dmp1 Promoter-Driven Diphtheria Toxin Receptor Transgene Expression Directs Unforeseen Effects in Multiple Tissues.
Al-Jazzar A, Javaheri B, Prideaux M, Boyde A, Scudamore CL, Cherifi C, Hay E, Hopkinson M, Boyd M, Cohen-Solal M, Farquharson C, Pitsillides AA. Al-Jazzar A, et al. Int J Mol Sci. 2016 Dec 26;18(1):29. doi: 10.3390/ijms18010029. Int J Mol Sci. 2016. PMID: 28035954 Free PMC article. - What is new in the management of rapidly progressive glomerulonephritis?
Greenhall GH, Salama AD. Greenhall GH, et al. Clin Kidney J. 2015 Apr;8(2):143-50. doi: 10.1093/ckj/sfv008. Epub 2015 Feb 19. Clin Kidney J. 2015. PMID: 25815169 Free PMC article. - Novel drugs and intervention strategies for the treatment of chronic kidney disease.
Lambers Heerspink HJ, de Zeeuw D. Lambers Heerspink HJ, et al. Br J Clin Pharmacol. 2013 Oct;76(4):536-50. doi: 10.1111/bcp.12195. Br J Clin Pharmacol. 2013. PMID: 23802504 Free PMC article. Review. - Glycemic memories and the epigenetic component of diabetic nephropathy.
Keating ST, El-Osta A. Keating ST, et al. Curr Diab Rep. 2013 Aug;13(4):574-81. doi: 10.1007/s11892-013-0383-y. Curr Diab Rep. 2013. PMID: 23639991 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous